Pyrimidine derivatives (I) are used as acetylcholinesterase inhibitors. Pyrimidine derivatives of formula (I) are used as acetylcholinesterase inhibitors. R 1, R 3 = H or optionally unsaturated 1-6C (cyclo)alkyl (optionally substituted by OH or halo); R 2 = aryl group (optionally substituted) or 1-4C optionally unsaturated (cyclo)alkyl (optionally substituted by halo, OH or heterocycle containing 1-5C and 1-5 heteroatoms selected from O, S or N); X 1 = S, N or O; X 3-X 5 = C or N, provided that no more than two are N; and Y 1 = O or S. Independent claims are also included for: (1) an insecticidal composition (II) comprising (I) together with a support to use (II) as an insecticide; and (2) an insecticidal kit comprising (II) associated with a diffusion means allowing the application of (II) on agricultural, dwelling, forest, marshy, steppe and/or savanna zones. [Image] ACTIVITY : Insecticide; Neuroprotective; Nootropic. MECHANISM OF ACTION : Acetylcholinesterase inhibitor. The ability of (I) to inhibit acetylcholinesterase was tested. The results showed that 5-[(5-methyl-2-furyl)methylene]-1-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione exhibited IC 50 value of 1.57 mu M and 0.65 mu M against mutated and normal acetylcholinesterases respectively.

1. Claims for the Contracting States : BE CH DE GB IT LI LU NL SE Pyroglutamic derivative, characterized in that it corresponds to the following formula (I) : see diagramm : EP0135444,P15,F2 in which : Y and Z have the following meanings : Y : -CO CH2 Cl see diagramm : EP0135444,P15,F3 see diagramm : EP0135444,P15,F4 Z : -COO CH3 ; Y : -CO CH2 Cl Z : -COO CH3 ; see diagramm : EP0135444,P15,F5 Z : -COO CH3 ; see diagramm : EP0135444,P15,F6 Z : -COO CH3 ; see diagramm : EP0135444,P15,F7 Z : -COO CH3 ; see diagramm : EP0135444,P16,F1 Z : -COOH ; Y : -COCH2 -Cl Z : -COOH 1. Claims for the Contracting State : AT Process for preparing a pyroglutamic derivative of the following formula (I) : see diagramm : EP0135444,P17,F2 in which : Y and Z have the following meanings : Y : -CO CH2 Cl see diagramm : EP0135444,P17,F3 see diagramm : EP0135444,P17,F4 Z : -COO CH3 ; Y : -CO CH2 Cl Z : -COO CH3 ; see diagramm : EP0135444,P17,F5 Z : -COO CH3 ; see diagramm : EP0135444,P17,F6 Z : -COO CH3 ; see diagramm : EP0135444,P17,F7 Z : -COO CH3 ; see diagramm : EP0135444,P17,F8 Z : -COOH ; Y : -COCH2 -Cl Z : -COOH characterized in that a compound of the following formula (II) : see diagramm : EP0135444,P17,F9 in which W is chosen from an ester group corresponding to Z defined above, or -COOSiMe3 group ; is reacted with an acylating agent such as an organic halide of formula Y-Hal, where Hal = halogen, especially chlorine, and where Y is defined as above, or with diketene ; and, in the case where W is a -COOSiMe3 group, the resulting intermediate product is converted to the corresponding acid or ester, for example by a hydrolysis or alcoholysis of this product.

3-Substituted 3,4-dihydrothieno[2,3-d]pyrimidin-4-one derivatives, production and use thereof. The invention relates to 3,4-dihydrothieno[2,3-d]pyrimidin-4-one derivatives which are substituted in position 3 by 5-membered heteroaryl which may be fused to an aryl or heteroaryl radical, where the heteroaryl and, if appropriate, the fused aryl or heteroaryl radical may have 1, 2 or 3 substituents selected independently of one another from C1-5-alkyl, C1-5-alkoxy, C1-5-alkylthio, halogen, CN, halo-C1-5-alkyl, halo-C1-5-alkoxy, hydroxy, -NH2, -N(R6)2, -NH(R6), aryl, aryloxy, aralkyl, aralkyloxy and heteroaryl, where the substituents aryl, aryloxy, aralkyl, aralkyloxy and heteroaryl may have 1, 2 or 3 substituents selected independently of one another from C1-5-alkyl, C1-5-alkoxy, C1-5-alkylthio, halogen, CN, halo-C1-5-alkyl, halo-C1-5-alkoxy, hydroxy, -NH2, -N(R6)2 and -NH(R6). The preparation and use of these derivatives, especially for therapeutic purposes, e.g. for the treatment of depressions, are likewise described.

A 5-aminopyrazole of the formula in which R1 represents alkoxycarbonyl, alkenyloxycarbonyl or alkinyloxycarbonyl, and R3, R4, R5, R6, and R7, which are identical or different, represent hydrogen, halogen, cyano, nitro, alkyl, alkoxy, alkylsulphonyl, alkoxycarbonyl or a radical -(X)n-R8 wherein X represents oxygen, sulphur, sulphinyl or sulphyonyl, n represents 0 or 1 and R8 represents halogenoalkyl, with the proviso that at least one of the radicals R3, R4, R5, R6 or R7 represents a radical -(X)n-R8, and R1 does not represent cyano if R1 represents trifluoromethyl, These compounds are intermediates useful in the preparation of herbicidally active substituted 5-acylamino-1-phenylpyrazoles.

Chemical patent from PubChem database. Patent Number: AT-E400571-T1. Title: Chemical Synthesis Method. Filing Date: 1992-05-09. Inventors: Yamamoto, Hiroshi, Schmidt, Hans. Abstract: A novel method for chemical synthesis is provided, utilizing specific catalysts and reaction conditions to achieve selective transformations with high... IPC Classifications: C07D, C07F, A61K. This patent covers 45 claims related to 3 chemical compounds. Useful for intellectual property research, prior art searches, and chemical innovation tracking.

1. Claims for Contracting States BE, CH, DE, FR, GB, IT, LI, NL Compounds of the general formula I see diagramm : EP0096142,P25,F1 wherein R1 is a fragment [X, Y, Z(phenyl)], [X, Y, Z(biphenyl)], [U, V, W(pyridyl)], [U, V, W(furyl)] or [U, V, W(thienyl)], wherein X, Y and Z are each independently hydrogen, halogen, C1 -C4 alkyl, C1 -C3 haloalkyl, di(C1 -C4 alkyl)amino, nitro, cyano, -COO(C1 -C4 alkyl), -CON(C1 -C4 alkyl)2 or the group -E-R4 , wherein E is -O-, -S-, -SO- or -SO2 -, R4 is C1 -C6 alkyl which is unsubstituted or substituted by C1 -C4 alkoxy, unsubstituted C3 -C5 alkenyl, C3 -C5 alkynyl which is unsubstituted or substituted by halogen or hydroxy, or is [X, Y, Z(phenyl)] or -CH2 -[X, Y, Z-(phenyl)] ; U, V and W are each independently hydrogen, halogen or C1 -C4 alkyl ; R2 is -COO(C1 -C6 alkyl), -CO-(C1 -C6 alkyl), -CO-N(C1 -C6 alkyl)2 , cyano, nitro, -SO2 -(C1 -C6 alkyl), -P(O)-(C1 -C6 alkoxy)2 or -SO2 -N(C1 -C6 alkyl)2 ; and R3 is C1 -C3 haloalkyl. 1. Claims for Contracting State AT A microbicidal composition for controlling or preventing an attack on living plants and/or for preserving perishable storable goods of vegetable or animal origin, which composition contains, as at least one active component, one of the compounds of the general formula I see diagramm : EP0096142,P27,F1 wherein R1 is a fragment [X, Y, Z(phenyl)], [X, Y, Z(biphenyl)], [U, V, W(pyridyl)], [U, V, W(furyl)] or [U, V, W(thienyl)], wherein X, Y and Z are each independently hydrogen, halogen, C1 -C4 alkyl, C1 -C3 haloalkyl, di(C1 -C4 alkyl)amino, nitro, cyano, -COO(C1 -C4 alkyl), -CON(C1 -C4 alkyl)2 or the group -E-R4 , wherein E is -O-, -S-, -SO- or -SO2 -, R4 is unsubstituted C1 -C6 alkyl, C3 -C5 alkenyl which is unsubstituted or substituted by halogen, C3 -C5 alkynyl which is unsubstituted or substituted by halogen or hydroxy, or is [X, Y, Z(phenyl)] or -CH2 -[X, Y, Z(phenyl)] ; U, V and W are each independently hydrogen, halogen or C1 -C4 alkyl ; R2 is -COO(C1 -C6 alkyl), -CO-(C1 -C6 alkyl), -CO-N(C1 -C6 alkyl)2 , cyano, nitro, -SO2 -(C1 -C6 alkyl), -P(O)-(C1 -C6 alkoxy)2 or -SO2 -N(C1 -C6 alkyl)2 ; and R3 is C1 -C3 haloalkyl.

Chemical patent from PubChem database. Patent Number: AT-E399777-T1. Title: Novel Pharmaceutical Composition. Filing Date: 1995-07-07. Inventors: Martinez, Carlos, Thompson, Emily. Abstract: The present invention relates to a novel pharmaceutical composition comprising one or more active pharmaceutical ingredients and pharmaceutically acce... IPC Classifications: C12N, C12P, A61K. This patent covers 36 claims related to 2 chemical compounds. Useful for intellectual property research, prior art searches, and chemical innovation tracking.

The present invention is directed to a novel form of a pyrrolopyridine-2-carboxylic acid amide of formula (I), which is an inhibitor of glycogen phosphorylase, compositions containing it and their use in therapy. The invention is also directed to processes for production of the novel form, novel intermediates used in said processes and processes for the production of said intermediates.

There are disclosed pyridine-2-ethers and pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring corresponding to the formula I the pyridine-N-oxides and/or amine oxides thereof and the pharmaceutically acceptable salts thereof. The compounds show analgesic activity.

Chemical patent from PubChem database. Patent Number: AT-E400271-T1. Title: Bioactive Compound and Applications. Filing Date: 2011-12-19. Inventors: Yamamoto, Hiroshi, Schmidt, Hans. Abstract: A bioactive compound and its applications in pharmaceutical and agricultural fields are described. The compound exhibits significant biological activi... IPC Classifications: C07H, A61K, A61P. This patent covers 32 claims related to 4 chemical compounds. Useful for intellectual property research, prior art searches, and chemical innovation tracking.